These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38718670)

  • 21. The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists.
    Kauppinen H; Ahonen R; Timonen J
    Int J Med Inform; 2017 Apr; 100():56-62. PubMed ID: 28241938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.
    Karia AM; Balane C; Norman R; Robinson S; Lehnbom E; Durakovic I; Laba TL; Joshi R; Webster R
    Int J Pharm Pract; 2020 Oct; 28(5):441-448. PubMed ID: 32347607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies.
    Odukoya OK; Stone JA; Chui MA
    J Am Pharm Assoc (2003); 2015; 55(1):52-8. PubMed ID: 25539495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
    MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
    J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-prescribing and access to prescription medicines during lockdown: experience of patients in Aotearoa/New Zealand.
    Imlach F; McKinlay E; Kennedy J; Morris C; Pledger M; Cumming J; McBride-Henry K
    BMC Fam Pract; 2021 Jul; 22(1):140. PubMed ID: 34210271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Violence in community pharmacy in Australia: incidence and implications.
    Peterson GM; Tan SI; Jackson SL; Naunton M
    Int J Clin Pharm; 2011 Apr; 33(2):264-72. PubMed ID: 21400069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Prescribers' Notes in Electronic Prescriptions in Ambulatory Practice.
    Dhavle AA; Yang Y; Rupp MT; Singh H; Ward-Charlerie S; Ruiz J
    JAMA Intern Med; 2016 Apr; 176(4):463-70. PubMed ID: 26954486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A qualitative exploration of mental health services provided in community pharmacies.
    Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
    PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. e-Prescribing: characterisation of patient safety hazards in community pharmacies using a sociotechnical systems approach.
    Odukoya OK; Chui MA
    BMJ Qual Saf; 2013 Oct; 22(10):816-25. PubMed ID: 23708439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying a whole systems lens to the general practice crisis: cross-sectional survey looking at usage of community pharmacy services in England by patients with long-term respiratory conditions.
    Hindi AMK; Schafheutle EI; Jacobs S
    BMJ Open; 2019 Nov; 9(11):e032310. PubMed ID: 31699746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Examination of the Prescription Renewal Process and Implications for Primary Care Physicians and Community Pharmacists.
    Pattin AJ; Devore N; Fowler J; Weldy D
    J Pharm Pract; 2020 Apr; 33(2):187-191. PubMed ID: 30222033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to electronic prescribing: Nebraska pharmacists' perspective.
    Lander L; Klepser DG; Cochran GL; Lomelin DE; Morien M
    J Rural Health; 2013; 29(1):119-24. PubMed ID: 23289663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do community pharmacies recover from e-prescription errors?
    Odukoya OK; Stone JA; Chui MA
    Res Social Adm Pharm; 2014; 10(6):837-852. PubMed ID: 24373898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retail pharmacy staff perceptions of design strengths and weaknesses of electronic prescribing.
    Odukoya O; Chui MA
    J Am Med Inform Assoc; 2012; 19(6):1059-65. PubMed ID: 22753809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Connecting primary care clinics and community pharmacies through a nationwide electronic prescribing network: A qualitative study.
    Gagnon MP; Payne-Gagnon J; Sicotte C; Langué-Dubé JA; Motulsky A
    J Innov Health Inform; 2015 Oct; 22(3):359-67. PubMed ID: 26577426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy and primary care perspectives on e-prescribing in a rural community: A focused ethnography.
    Kooienga S; Singh RL
    Res Social Adm Pharm; 2017; 13(4):820-830. PubMed ID: 27624860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-prescription errors and their resolution in a community compounding pharmacy.
    Reed-Kane D; Vasquez K; Pavlik A; Peragine J; Sandberg M
    Int J Pharm Compd; 2014; 18(2):159-61. PubMed ID: 24881120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists' Experiences, Perceptions, and Knowledge of Direct-to-Consumer Prescription Coupons.
    Gernant SA; Polomoff CM; Marsh J; Martineau S; Hardie C; Jeffery SM
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1130-1137. PubMed ID: 32857654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.